Crexendo insider sales reported in Form 144

Crexendo, Inc. reports proposed and recent resale activity by a shareholder under Form 144.

Rhea-AI Filing Summary

Crexendo, Inc. reports proposed and recent resale activity by a shareholder under Form 144. The filing lists multiple off‑market sales by Vincent Ron on 05/04/2026, 05/05/2026, 05/06/2026, 05/07/2026, 05/22/2026, and 05/26/2026, with per‑trade share amounts of 18,989, 10,000, 33,550, 1,450, 29,000, and 46,000 respectively. The record also shows prior equity compensation vesting events of 50,000 and 40,000 shares in 04/09/2021 and 11/09/2021.

Insights

Securities Compliance Analyst

Form 144 lists multiple resale transactions by a single holder across May 2026.

The excerpt shows sequential sales by Vincent Ron on 05/04/2026, 05/05/2026, 05/06/2026, 05/07/2026, 05/22/2026, and 05/26/2026 with stated share counts per trade. These entries are typical notices required for certain restricted or control stock resales.

Timing and method details for each sale (broker, block trade, or private placement) are not provided in the excerpt; subsequent filings or trade reports would show execution specifics and cash‑flow recipients.

Key Figures

Sale on 05/04/2026: 18,989 shares Sale on 05/05/2026: 10,000 shares Sale on 05/06/2026: 33,550 shares +5 more

8 metrics

Sale on 05/04/2026 18,989 shares trade date <date>05/04/2026</date>

Sale on 05/05/2026 10,000 shares trade date <date>05/05/2026</date>

Sale on 05/06/2026 33,550 shares trade date <date>05/06/2026</date>

Sale on 05/07/2026 1,450 shares trade date <date>05/07/2026</date>

Sale on 05/22/2026 29,000 shares trade date <date>05/22/2026</date>

Sale on 05/26/2026 46,000 shares trade date <date>05/26/2026</date>

Vested equity (example) 50,000 shares vesting date <date>04/09/2021</date>

Vested equity (example) 40,000 shares vesting date <date>11/09/2021</date>

Key Terms

Form 144, Vesting of Stock Options, Equity Compensation

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Vesting of Stock Options financial

"Vesting of Stock Options | Crexendo, Inc."

Equity Compensation financial

"Equity Compensation Common Stock"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Crexendo (CXDO) Form 144 disclose about Vincent Ron's sales?

The filing lists six sales by Vincent Ron in May 2026 with share amounts of 18,989; 10,000; 33,550; 1,450; 29,000; and 46,000. The entries record trade dates between 05/04/2026 and 05/26/2026 and show broker information for one listed broker.

Do the entries show when Vincent Ron acquired the shares sold?

The excerpt shows historical equity compensation vesting of 50,000 shares on 04/09/2021 and 40,000 shares on 11/09/2021. Those vesting lines provide acquisition dates for some holdings that may underlie the resales.

Does the Form 144 state the proceeds or prices for the May 2026 sales?

The provided excerpt lists share quantities and dates but does not include per‑share sale prices or aggregate proceeds for the May 2026 transactions. Price and proceeds details are not shown in the excerpt.

Is there broker information included in the Form 144 excerpt for CXDO?

Yes; the excerpt names a broker entry for Muriel Siebert & Co., Inc. with an address in Miami Beach and appears with a numeric code sequence. Full broker execution details are not included beyond that reference.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/03/2026 - 11:15 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001550497
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Crexendo, Inc.
SEC File Number	001-32277
Address of Issuer	1225 W Washington St. Suite 213 Tempe ARIZONA 85288
Phone	6027148500
Name of Person for Whose Account the Securities are To Be Sold	Vincent Ron
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	OFFICER

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Muriel Siebert & Co., Inc. 653 Collins Ave Miami Beach FL 33139	90000	902827	32415373	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	04/09/2021	Vesting of Stock Options	Crexendo, Inc.			50000	04/09/2021	Equity Compensation
Common Stock	11/09/2021	Vesting of Stock Options	Crexendo, Inc.			40000	11/09/2021	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	05/04/2026	18989	154501
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	05/05/2026	10000	86280
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	05/06/2026	33550	314002
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	05/07/2026	1450	14138
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	05/22/2026	29000	283393
Vincent Ron 3984 East Hummingbird Lane Phoenix AZ 85050	Common	05/26/2026	46000	452824

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the monthly vesting of 50,000 stock options during the period of 4/9/2021 through 3/9/2024 for stock options that were granted on 3/9/2021 and 40,000 during the period of 12/9/2021 through 11/9/2024 for stock options that were granted on
Date of Notice	06/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ron Vincent
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)